| 000 | 00953 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516170115.0 | ||
| 264 | 0 | _c20131205 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(13)61756-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMay, Andreas E | |
| 245 | 0 | 0 |
_aAntiplatelet therapy after coronary stenting: for how long? _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 2013 |
||
| 300 |
_a1684-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aCoronary Artery Disease _xtherapy |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xmethods |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 773 | 0 |
_tLancet (London, England) _gvol. 382 _gno. 9906 _gp. 1684-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(13)61756-0 _zAvailable from publisher's website |
| 999 |
_c23059437 _d23059437 |
||